Seres Therapeutics, Inc.
Ticker: 1609809
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q3 FY2023 | Q2 FY2023 | Q2 FY2023 | Q1 FY2023 | Q1 FY2023 | Q3 FY2022 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.36+2.9% | 0.35+12.9% | 0.31-99.8% | 126.47+0.0% | 126.47+24421.2% | -0.52+0.0% | -0.52-115.1% | 3.44 |
| Total Income | 0.36+2.9% | 0.35+12.9% | 0.31-99.8% | 126.47+0.0% | 126.47+24421.2% | -0.52+0.0% | -0.52-115.1% | 3.44 |
| EXPENSES | ||||||||
| Expenditure | 21.27-6.8% | 22.83-52.2% | 47.72-38.0% | 76.95+0.0% | 76.95+9.9% | 70.05+0.0% | 70.05+12.0% | 62.55 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
| PROFIT | ||||||||
| Net Profit | -19.91-342.8% | 8.20+117.1% | -47.85-202.8% | 46.55+0.0% | 46.55+165.4% | -71.17+0.0% | -71.17-18.6% | -60.00 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00%-139.16pp | 39.16% | 39.16%-60.84pp | 100.00% | 100.00%+200.00pp | -100.00% |
| NPM % | -100.00%-200.00pp | 100.00%+200.00pp | -100.00%-136.81pp | 36.81% | 36.81%-63.19pp | 100.00% | 100.00%+200.00pp | -100.00% |
| EPS | -2.08-321.3% | 0.94+354.1% | -0.37-202.8% | 0.36+0.0% | 0.36+163.2% | -0.57+0.0% | -0.57-16.3% | -0.49 |
Corporate Events
Board MeetingMCRB
202631May
Board Meeting
Director Resignation — Hans-Juergen Woerle resigned from the…
SEC Filing ↗